[go: up one dir, main page]

KR900017611A - 개의 코로나 바이러스 백신 - Google Patents

개의 코로나 바이러스 백신 Download PDF

Info

Publication number
KR900017611A
KR900017611A KR1019900006177A KR900006177A KR900017611A KR 900017611 A KR900017611 A KR 900017611A KR 1019900006177 A KR1019900006177 A KR 1019900006177A KR 900006177 A KR900006177 A KR 900006177A KR 900017611 A KR900017611 A KR 900017611A
Authority
KR
South Korea
Prior art keywords
dog
corona virus
virus strain
canine
coronavirus
Prior art date
Application number
KR1019900006177A
Other languages
English (en)
Other versions
KR0142081B1 (ko
Inventor
바센다일 윌리암
스튜어트 케네디 차머즈 윌리암
Original Assignee
에프. 게. 엠 헤르만 아. 게. 제이 베르메렌
악조 엔. 브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 게. 엠 헤르만 아. 게. 제이 베르메렌, 악조 엔. 브이. filed Critical 에프. 게. 엠 헤르만 아. 게. 제이 베르메렌
Publication of KR900017611A publication Critical patent/KR900017611A/ko
Application granted granted Critical
Publication of KR0142081B1 publication Critical patent/KR0142081B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

개의 코로나 바이러스 백신
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 개의 코로나 바이러스 감염중 임상 효과에 대해 민감성 동물을 보호하는 백신은 프랑스공화국, 파리에 소재하는 엥스뛰뛰 빠스떼르 국립 미생물 배양 수집소에 수탁 번호 제I-743호로 기탁된 개에서 얻은 코로나 바이러스 균주의 항원형 바이러스 균주에서 얻은 것임을 특징으로 하는 백신.
  2. 제1항에 있어서, 프랑스공화국, 파리에 소재하는 엥스뛰뛰 빠스떼르 국립 미생물 배양 수집소에 수탁 번호 제I-743호로 기탁된 개의 코로나 바이러스 균주에서 얻은 것임을 특징으로 하는 백신.
  3. 개의 코로나 바이러스 균주 제I-743호의 혈청형인 개의 코로나 바이러스의 순수 배양물.
  4. 제3항에 있어서, 개의 코로나 바이러스 균주 제I-743호인 순수 배양물.
  5. 개의 코로나 바이러스 백신을 제조하는 방법에 있어서,개의 코로나 바이러스 균주 제I-743호의 항원형인 개의 코로나 바이러스를 백신 사용에 적합한 형태로 변형시키는 것을 특징으로 하는 방법.
  6. 개의 코로나 바이러스 감염증에 민감한 동물을 보호하는 방법에 있어서 또는 제1항 또는 제2항의 백신을 동물에 투여하는 것을 특징으로 하는 방법.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019900006177A 1989-05-03 1990-05-01 개의 코로나 바이러스 백신 KR0142081B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89304441 1989-05-03
EP89304441.2 1989-05-03

Publications (2)

Publication Number Publication Date
KR900017611A true KR900017611A (ko) 1990-12-19
KR0142081B1 KR0142081B1 (ko) 1998-06-01

Family

ID=8202669

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900006177A KR0142081B1 (ko) 1989-05-03 1990-05-01 개의 코로나 바이러스 백신

Country Status (12)

Country Link
US (2) US5232694A (ko)
EP (1) EP0396193B1 (ko)
JP (1) JP2892767B2 (ko)
KR (1) KR0142081B1 (ko)
AU (1) AU630186B2 (ko)
CA (1) CA2015828C (ko)
DE (1) DE69014974T2 (ko)
DK (1) DK0396193T3 (ko)
ES (1) ES2068322T3 (ko)
HU (1) HU214739B (ko)
NZ (1) NZ233509A (ko)
ZA (1) ZA903142B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
US6033845A (en) * 1996-12-18 2000-03-07 Engene Biotechnologies Inc Specific diagnostic for feline infectious peritonitis antibodies
AU2005200757A1 (en) * 2005-02-21 2006-09-07 Peter Henry Scott An Insect Attractant Composition and Trap Containing Same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
EP0138242A1 (en) * 1983-09-07 1985-04-24 Duphar International Research B.V Method of preparing DNA complementary to the genome of coronaviruses
WO1988001292A1 (en) * 1986-08-22 1988-02-25 Board Of Regents, The University Of Texas System Human enteric coronavirus
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine

Also Published As

Publication number Publication date
JP2892767B2 (ja) 1999-05-17
CA2015828A1 (en) 1990-11-03
DE69014974T2 (de) 1995-05-18
AU5474190A (en) 1990-11-08
DE69014974D1 (de) 1995-01-26
KR0142081B1 (ko) 1998-06-01
CA2015828C (en) 1999-07-13
US5464621A (en) 1995-11-07
AU630186B2 (en) 1992-10-22
ZA903142B (en) 1991-02-27
EP0396193B1 (en) 1994-12-14
HUT56287A (en) 1991-08-28
US5232694A (en) 1993-08-03
EP0396193A1 (en) 1990-11-07
HU902644D0 (en) 1990-09-28
NZ233509A (en) 1992-05-26
JPH02295934A (ja) 1990-12-06
ES2068322T3 (es) 1995-04-16
DK0396193T3 (da) 1995-02-27
HU214739B (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
Kocan et al. Anaplasmosis control: past, present, and future
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
ATE50913T1 (de) Impfstoff gegen hundecoronavirus.
DE3677494D1 (de) Virus-impfstoff.
PT815235E (pt) Vacinas para peste
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
DE69330794D1 (de) Markiertes Interleukin-8 und seine medizinische Anwendung
MY103575A (en) Cannie coronavirus vaccine
ATE297218T1 (de) Impfstoff gegen mehrere fiv-subtypen
KR900017611A (ko) 개의 코로나 바이러스 백신
US4040904A (en) Novel rabies virus vaccine and processes
Elzein et al. Severe Long‐Lasting Contagious Ecthyma Infection in a Goat's Kid
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
McLelland et al. Serologic responses of Barbary sheep (Ammotragus lervia), Indian antelope (Antilope cervicapra), wallaroos (Macropus robustus), and chimpanzees (Pan troglodytes) to an inactivated encephalomyocarditis virus vaccine
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
ES2063048T3 (es) Vacuna para proteccion de gatos contra la peritonitis infecciosa felina.
Frisch Mouthrot in farmed Atlantic salmon
ATE112490T1 (de) Lebende newcastle-krankheit-virus-vakzine.
Meanger et al. Immune response to avian reovirus in chickens and protection against experimental infection
ES2052883T3 (es) Cultivo de celulas de riñon de cerdo y su uso en la produccion de vacunas.
Crăcea Q fever epidemiology in Roumania
Avila et al. Argentine hemorrhagic fever: A biologic marker
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
JPS56115724A (en) Prophilaxis and remedy for avian infectious coryza
Morton Laboratory and field trials of killed Brucella suis type 4 vaccine in reindeer

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19900501

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19940830

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19900501

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19971023

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19971229

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19980326

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19980326

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20010321

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20020320

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20030320

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20040319

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20050318

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20060323

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20060323

Start annual number: 9

End annual number: 9

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20080610